Sort
40,608 grants matching “prostate cancer”
Mechanisms of resistance to treatment in aggressive prostate cancers
$901,721Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular alterations driving the development of primary prostate cancers
$901,721Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
$901,531Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2010 · CA
DISCOVERY AND FUNCTIONAL ANALYSES OF SUSCEPTIBILITY GENES FOR LETHAL PROSTATE CANCER
$900,892The Johns Hopkins University · · FY2019 · Defense Health Agency
INTEGRATIVE MOLECULAR PROFILING OF WHOLE URINE IN AFRICAN AMERICAN MEN WITH AGGRESSIVE PROSTATE CANCER
$900,875Regents Of The University Of Michigan · · FY2021 · Defense Health Agency
Exploring Precision Oncology: From Gene Fusions to lncRNAs
$900,791Arul M Chinnaiyan · University Of Michigan At Ann Arbor · R35 · FY2019 · CA
FUNCTIONAL CHARACTERIZATION OF FORKHEAD-DOMAIN MISSENSE MUTATIONS OF FOXA1 IN DRIVING PROSTATE CANCER PROGRESSION
$900,773University Of Mass At Boston · · FY2019 · Defense Health Agency
Epigenetics, Stem Cells, and Cancer
$900,709Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2010 · CA
TARGETING CHROMATIN REMODELING COMPLEXES TO INHIBIT ONCOGENIC ANDROGEN RECEPTOR ACTIVITY IN PROSTATE CANCER.
$900,640Regents Of The University Of Michigan · · FY2021 · Department of the Army
Development of PSMA -based recombinant protein vaccines
$900,492Progenics Pharmaceuticals, Inc. · R44 · FY2005 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$900,224Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
PSMA GLYCOSYLATION AND AGGRESSIVE PROSTATE CANCER PROGRESSION
$900,000Old Dominion University · · FY2018 · Department of the Army
Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer Suscepti
$899,954Gail S Prins · University Of Illinois At Chicago · RC2 · FY2009 · ES
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$899,782Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2014 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$899,708William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities
$898,724Craig M Crews · Yale University · R35 · FY2023 · CA
DCEG- GWAS Studies
$898,719Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
STEREOTACTIC BODY RADIATION THERAPY FOR UNDERSERVED POPULATIONS OF MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER
$898,667The University Of Texas Southwestern Medical Center · · FY2008 · Department of Defense
EXPLOITING REAL-WORLD CLINICAL GENOMIC DATA TO DISCOVER BIOMARKERS AND ADDRESS OUTCOME DISPARITY FOR PROSTATE CANCER
$898,342Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
High throughput infrastructure for reaction screening and bioassays
$898,292Robert Graham Cooks · Purdue University · UG3 · FY2022 · TR
H. LEE MOFFITT CANCER CENTER CCOP RESEARCH BASE
$898,139University Of South Florida · U10 · FY2004 · CA
Developmental Exposure to Low-dose Bisphenol A and Human Prostate Cancer Suscepti
$898,116Gail S Prins · University Of Illinois At Chicago · RC2 · FY2010 · ES
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$898,049Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2017 · CA
HSP90 and HSP7Chaperone Proteins and Interactors in Cellular Signal Transduction
$897,836Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$897,597Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2013 · CA